**Core Concept**
Ursodeoxycholic acid (UDCA) is a secondary bile acid that plays a crucial role in the treatment of various liver and biliary diseases. It is a naturally occurring bile acid that is synthesized from chenodeoxycholic acid by intestinal bacteria.

**Why the Correct Answer is Right**
UDCA has a unique chemical structure that allows it to form a stable, non-toxic complex with cytotoxic bile acids, thereby reducing their cytotoxic effects on liver cells. This property makes UDCA an effective treatment for conditions such as primary biliary cirrhosis, primary sclerosing cholangitis, and certain cases of intrahepatic cholestasis. The exact mechanism of action of UDCA involves its ability to inhibit the synthesis of toxic bile acids, promote bile flow, and reduce oxidative stress in the liver.

**Why Each Wrong Option is Incorrect**
**Option A:** UDCA is not a primary bile acid.
* UDCA is a secondary bile acid, synthesized from chenodeoxycholic acid by intestinal bacteria.

**Option B:** UDCA is not a choleretic agent.
* While UDCA does promote bile flow, its primary mechanism of action is the formation of stable complexes with cytotoxic bile acids, rather than directly increasing bile flow.

**Option C:** UDCA is not a hepatotoxic agent.
* UDCA is actually used to treat liver and biliary diseases, rather than causing harm to the liver.

**Clinical Pearl / High-Yield Fact**
One important clinical consideration when using UDCA is its potential to interact with other medications, such as warfarin and cyclosporine. Patients taking UDCA should be monitored closely for signs of bleeding or other adverse effects.

**Correct Answer: D. Ursodeoxycholic acid is a secondary bile acid.**